Inherited deleterious variants in BRCA1 and BRCA2 genes are highly penetrant for HBOC, with lifetime risks (dependent upon the gene and population) up to 57% for breast cancer and up to 40% and 18% for ovarian cancer for BRCA1 and BRCA2 carriers, respectively [1]. The gene discussed is BRCA2; the disease is breast carcinoma.